Share  Email

Posted on: 26-Jun-2008

Page Views: 1917

To view full screen click here!



Loading....

If you are unable to view this PDF file, please clear the browser cache and reload your page,
if the problem persists try upgrading your PDF reader. To obtain the PDF reader, please click here

Summary

I hope you enjoy this week's Maxim on how Genentech rewrote the rules of drug marketing. It is a delightful weave of science, statistics, and marketing. -- Dan So you’re in marketing? What would your management do if they found out you had passed up an opportunity to gain millions of impressions – many with the top managements of your customers – for free? Shouldn’t you be posting your releases and white papers at weSRCH.com? Transform Your Presentations & White Papers into Global Promotional Tools! Webprint at weSRCH.com. All you have to do is sign-up for a free membership and then you can post what you want. Go gain access to thousands of readers – many in top management – and it doesn’t cost you a penny. weSRCH: Hits per Month: 5.6 million Page Views per Month*: 2.7 million Readers (unique visitors): 85 thousand Pages Read Per Person*: 39 Average Income: 144 thousand Regional Distribution: * Multi-page PDF’s counted as 1 page. Since most papers are multi-page PDFs, these numbers are conservative.

« Maxims applied: Energy Conversion Devices and thei...

weSTREETweek: the HOTTEST STOCKS were mostly medic... »

About weQuest:
weQuest's are written by G Dan Hutcheson, his career spans more than thirty years, in which he became a well-known as a visionary for helping companies make businesses out of technology. This includes hundreds of successful programs involving product development, positioning, and launch in Semiconductor, Technology, Medicine, Energy, Business, High Tech, Enviorntment, Electronics, healthcare and Business devisions.

Short URL: https://www.wesrch.com/medical/weqME12VVA

Send to Colleague | Send to myContacts |  Save to myLibrary

 
weSRCH App on Apple